Progenics presents PRO 542 data

In a Phase I/II study in 18 children, PGNX's PRO 542 CD4 receptor/human antibody fusion protein gave up to a 1.5 log reduction in HIV RNA levels in the 6 patients receiving four weekly PRO 542 doses. ...